(Q34105498)

31 July 2017

1 reference

title

Treatment and prevention of antibiotic associated diarrhea (English)

1 reference

31 July 2017

0 references

1 reference

Bergogne-Bérézin E

1

1 reference

31 July 2017

publication date

1 December 2000

1 reference

International Journal of Antimicrobial Agents

31 July 2017

published in

1 reference

31 July 2017

volume

16

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

521-526

1 reference

Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900293-4

7 January 2021

Epidemiology, risk factors and treatments for antibiotic-associated diarrhea.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900293-4

7 January 2021

Antibiotic-associated diarrhoea, Clostridium difficile, and short-chain fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900293-4

7 January 2021

Recurrent Clostridium difficile disease: epidemiology and clinical characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900293-4

7 January 2021

Mechanisms and management of antibiotic-associated diarrhea.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900293-4

7 January 2021

Review article: treatment of Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900293-4

7 January 2021

Pseudomembranous colitis: causes and cures

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900293-4

7 January 2021

Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900293-4

7 January 2021

Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900293-4

7 January 2021

Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900293-4

7 January 2021

Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900293-4

7 January 2021

Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900293-4

7 January 2021

Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900293-4

7 January 2021

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900293-4

7 January 2021

Living in the 'post-antibiotic era': could the use of probiotics be an effective strategy?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900293-4

7 January 2021

10.1016/S0924-8579(00)00293-4

Identifiers

DOI

1 reference

31 July 2017

1 reference